Radiolabelled amines and the lung

Nuclear Medicine Communications

Volumn 19, Issue 9, 1998, Pages 817-822

  Peters, A M ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; 2 [[N (3 DIMETHYLAMINOPROPYL) N METHYLAMINO]METHYL] 4 IODO 6 METHYLPHENOL I 123; AMINE; HALOTHANE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; INOSINE PHOSPHATE; IODINE 123; ISOFLURANE; RADIOISOTOPE;

DRUG CLEARANCE; DRUG METABOLISM; DRUG UPTAKE; EDITORIAL; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG PERFUSION; LUNG SCINTISCANNING; MEASUREMENT;

ANIMALS; HUMANS; IODINE RADIOISOTOPES; IODOBENZENES; IOFETAMINE; LUNG; RADIOPHARMACEUTICALS; TECHNETIUM;

EID: 0031787312     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199809000-00001     Document Type: Article

References (37)

1. Slosman DO, Brill AB, Polla BS, Alderson PO. Evaluation of [iodine-12 5]N, N, N ’-trimethyl-N ’-[2-hydroxy-3-methyl-5-iodobenzyl]-l,3-propanediamine lung uptake using an isolated-perfused lung model. J Nucl Med 1987; 28: 203-208.
2. Rahimian J, Glass EC, Touya JJ, Akber SF, Graham LS, Bennett LR. Measurement of metabolic extraction of tracers in the lung using a multiple indicator dilution technique. J Nucl Med 1984; 25: 31-37.
3. Abrams DN, Man SF, Noujaim AA. Evaluation of the lung uptake of iodine-131 HIPDM by the single-pass multiple indicator dilution technique in a rabbit model. J Nucl Med 1987; 28: 487-494.
4. Akber SE. On the theory of the measurement of the first-pass pulmonary extraction using the indicator dilution technique. Nuklearmedizin 1987; 26: 20-27.
5. Akber SF. A noninvasive assessment of pharmacological interaction of amines in the lung. Nucl Med Commun 1987; 8: 889-893.
6. Touya JJ, Rahimian J, Grubbs DE, Corbus HF, Bennett LR. A non-invasive procedure for in vivo assay of a lung amine endothelial receptor. J Nucl Med 1985; 26: 1302-1307.
7. Touya JJ, Rahimian J, Grubbs DE et al. The lung as a metabolic organ. Sem Nucl Med 1986; 16: 296-305.
8. Pistolesi M, Miniati M, Petruzzelli Set al. Pulmonary retention of iodobenzyl propanediamine in humans: Effect of cigarette smoking. Am Rev Respir Dis 1988; 138: 1429-1433.
9. Miniati M, Paci A, Cocci F, Ciarimboli G, Monti S, Pistolesi M. Mitochondria act as a reservoir for the basic amine HIPDM in the lung. Eur Respir J 1996; 9: 2306-2312.
10. Yoekura Y, Fujita T, Nishizawa S, Iwasaki Y, Mukai T, Konishi J. Temporal changes in accumulation of N-isopro-pyl-p-iodoamphetamine in human brain: Relation to lung clearance. J Nucl Med 1989; 30: 1977-1981.
11. Gunaydin B, Karadenizli Y, Babacan A et al. Pulmonary microvascular injury following general anaesthesia with volatile anaesthetics-halothane and isoflurane: A comparative clinical and experimental study. Respir Med 1997; 91: 351-360.
12. Yeh SH, Liu RS, Wu LC, Wang SJ, Lu JY. 99Tcm-HMPAO and 99Tcm-DTPA radioaerosol clearance measurements in idiopathic pulmonary fibrosis. Nucl Med Commun 1995; 16: 140-144.
13. Kao CH, Wang RC, Lin HT, Yu SL, Wang SJ, Chiang CD. Alveolar integrity in pulmonary emphysema using techne-tium-99m-DTPA and technetium-99m-HMPAO radioaerosol inhalation lung scintigraphy. J Nucl Med 1995; 36: 68-72.
14. Kao CH, Lin HT, Yu SL, Wang SJ, Yeh SH. The supine lung clearance of Tc-99m DTPA and HMPAO aerosols. Clin Nucl Med 1995; 20: 633-635.
15. Shih WJ, Lee JK, Coupal J, Lai YL, Gruenwald F, Biersack H. Diminished Tc-99m HMPAO pulmonary uptake in exsmokers. Clin Nucl Med 1995; 20: 788-791.
16. Shih WJ, Gruenwald F, Biersack HJ et al. Tc-99m HMPAO diffuse pulmonary uptake demonstrated in cigarette smokers. Clin Nucl Med 1991; 16: 668-672.
17. Suga K, Uchisako H, Nishigauchi K et al. Technetium-99m-HMPAO as a marker of chemical and irradiation lung injury: Experimental and clinical investigations. J Nucl Med 1994; 35: 1520-1527.
18. Van Zandwijk N, Zwijnenburg A, Hoefhagel CA, Marcuse HR. N-isopropyl-123Tp-iodoamphetamine, a new agent for lung imaging studies. Thorax 1986; 41: 801-803.
19. Moretti JL, Holman BL, Delmon L et al. Effect of antidepressant and narcoleptic drugs on N-isopropyl-p-iodoamphetamine biodistribution in animals. J Nucl Med 1987; 28: 354-359.
20. Slosman DO, Donath A, Alderson PO. 131I-metaiodoben-zylguanidine and 125I-iodoamphetamine: Parameters of lung endothelial cell function and pulmonary vascular area. Eur J Nucl Med 1989; 15: 207-210.
21. Slosman DO, Polla BS, Donath A. 123I-MIBG pulmonary removal: A biochemical marker of minimal lung endothelial cell lesions. Eur J Nucl Med 1990; 16: 633-637.
22. Suga K, Ariyoshi I, Nakanishi T, Utsumi H, Yamada N. Clinical and experimental studies on the mechanism of abnormal accumulation in lung scanning with 123I-IMP. Nucl Med Commun 1992; 13: 33-40.
23. Costa DC, Ell PJ, Cullum ID, Jarritt PH. The in vivo distribution of 99Tcm-HMPAO in normal man. Nucl Med Commun 1986; 7: 647-658.
24. Hughes JMB. Radionuclides and the lung: Past, present and future. AJR 1990; 155: 455-463.
25. Arnot RN, Takagi H, Hughes JMB, Royston D, Peters AM, Lavender JP. Lung studies with a lipophilic aerosol of 99Tcm-labelled HMPAO (abstract). Nucl Med Commun 1988; 9: 166.
26. Quing F, Rhodes CG, Hayes MJ et al. In vivo quantification of human pulmonary beta-adrenoreceptor density using PET: Comparison with in vitro radioligand binding. J Nucl Med 1996; 37: 1275-1281.
27. Paci A, Ciarimboli G, Miniati M, Cocci F, Piras F, Pistolesi M. Lung tissue binding of iodobenzyl-propanediamine: Involvement of beta-adrenergic receptors. J Pharm Biomed Anal 1989; 7: 1467-1472.
28. Shih WJ, Lai YL, Coupal JJ, Simmons G. [123I]HIPDM pulmonary imaging demonstrates elastase-induced pulmonary emphysema. Lung 1993; 171: 31-41.
29. Shih WJ, Cottrill CM, Coupal JJ, O’Connor W, Kung HF, Ryo UY. Iodine-123-HIPDM lung imaging in pulmonary vein-banded pulmonary hypertension. J Nucl Med 1990; 31: 668-673.
30. Crone C, Levitt DG. Capillary permeability to small solutes. In: Renkin EM, Michel CC, eds. Handbook of physiology, section 2: The cardiovascular system IV. Bethesda, MD: American Physiological Society, 1984: 375-409.
31. Sapirstein LA. Regional blood flow by fractional distribution of indicators. Am J Physiol 1958; 193: 161-168.
32. Petruzzelli S, Palla A, Prediletto R, Mazzuca N, Pistolesi M. SPECT perfusion imaging with 123I-HIPDM in a patient with pulmonary embolism. J Nucl Med Allied Sci 1989; 33: 45-48.
33. Hirose Y, Hayashida K, Ishida Y, Takamiya M, Nishimura T. I-123-iodoamphetamine lung scanning in patients with ventilation-perfusion mismatching. Clin Nucl Med 1995; 20: 421-425.
34. Miniati M, Cocci F, Pad A, Giani L, Pistolesi M. Evaluation of non-respiratory function of the human lung by HIPDM lung scanning. Clin Physiol 1992; 12: 1-9.
35. Shih WJ, Coupal JJ, Dillon ML, Kuang HF. Application of 123I-HIPDM as a lung imaging agent. Eur J Nucl Med 1988; 14: 21-24.
36. Suga K, Sadanaga Y, Nishigauchi K, Uchisako H, Nakanishi T. Lobar primary pulmonary lymphoma: Iodine-123-iodoamphetamine and thallium-201-chloride scintigraphic findings. J Nucl Med 1993; 34: 1980-1983.
37. Nagamachi S, Inoue K, Hoshi H et al. Lung scintigraphy with [123]IMP in patients with pulmonary tuberculosis. Int J Rad Appl Instrum B 1992; 19: 399-404.